Effectiveness of Clinical Decision Tools in Predicting Pulmonary Embolism [0.03%]
临床决策工具在预测肺栓塞方面的有效性
Michael A Simon,Christopher Tan,Patrick Hilden et al.
Michael A Simon et al.
Objective: The Wells criteria and revised Geneva score are two commonly used clinical decision tools (CDTs) developed to assist physicians in determining when computed tomographic angiograms (CTAs) should be performed to ...
Prevalence of Latent Tuberculosis Infection in the Middle East and North Africa: A Systematic Review [0.03%]
中东和北非地区潜伏性结核感染的流行情况：一项系统评价
Mazin Barry
Mazin Barry
Objective: Data on the prevalence of latent tuberculosis infection (LTBI) in Middle Eastern and North African countries are scarce. We aimed to review all relevant published data in countries belonging to this region to d...
Safety and Feasibility of a Novel Protocol for Percutaneous Dilatational Tracheostomy in Patients with Respiratory Failure due to COVID-19 Infection: A Single Center Experience [0.03%]
一项新的经皮扩张气管切开术在COVID-19呼吸衰竭患者中安全性和可行性的单中心研究体验
Ziad Boujaoude,Nagendra Madisi,Bhavi Patel et al.
Ziad Boujaoude et al.
Introduction: The rapidly spreading Novel Coronavirus 2019 (COVID-19) appeared to be a highly transmissible pathogen in healthcare environments and had resulted in a significant number of patients with respiratory failure...
Association of Vitamin D Deficiency and Newly Diagnosed Pulmonary Tuberculosis [0.03%]
维生素D缺乏与新诊断的肺结核的关系
Vijay Jaimni,Barkur Ananthakrishna Shasty,Sharath P Madhyastha et al.
Vijay Jaimni et al.
Introduction: Vitamin D has a significant role in host immune defense against Mycobacterium tuberculosis. It has been suggested that pulmonary tuberculosis may be associated with lower levels of vitamin D. Present study w...
The Prevalence of the EML4-ALK Fusion Gene in Cytology Specimens from Patients with Lung Adenocarcinoma [0.03%]
细胞学标本中肺腺癌患者EML4-ALK融合基因的检出率分析
Didik S Heriyanto,Ika Trisnawati,Evan G Kumara et al.
Didik S Heriyanto et al.
Background: Under the National Comprehensive Cancer Network (NCCN) guidelines for non-small-cell lung carcinoma (NSCLC), anaplastic lymphoma kinase (ALK) gene rearrangement is required to be assessed. However, data showin...
Observational Study
Pulmonary medicine. 2020 Dec 23:2020:3578748. DOI:10.1155/2020/3578748 2020
Role of the Bronchoalveolar Lavage in Noncritically Ill Patients during the SARS-CoV-2 Epidemic [0.03%]
SARS-CoV-2流行期间支气管肺泡灌洗在非重症患者中的作用
Olivier Taton,Emmanuelle Papleux,Benjamin Bondue et al.
Olivier Taton et al.
Background: Bronchoalveolar lavage (BAL) is currently not recommended in noncritically ill patients for the diagnosis of SARS-CoV-2 infection. Indeed, the diagnosis is based on the RT-PCR test on a nasopharyngeal swab (NP...
Multicenter Study
Pulmonary medicine. 2020 Dec 17:2020:9012187. DOI:10.1155/2020/9012187 2020
Corrigendum to "Patient Delay in Initiating Tuberculosis Treatment and Associated Factors in Oromia Special Zone, Amhara Region" [0.03%]
“奥罗米亚特殊专区肺结核治疗患者延迟及影响因素”的勘误公告
Muhammed Abdu,Awraris Balchut,Eshetu Girma et al.
Muhammed Abdu et al.
[This corrects the article DOI: 10.1155/2020/6726798.]. Copyright © 2020 Muhammed Abdu et al.
Published Erratum
Pulmonary medicine. 2020 Nov 10:2020:9505083. DOI:10.1155/2020/9505083 2020
Neutrophil Oxidized-Modified Proteins and Neutrophil Extracellular Traps in Patients with Community-Acquired Pneumonia [0.03%]
社区获得性肺炎患者中性粒细胞氧化修饰蛋白及中性粒细胞外陷阱的研究
Vilen Molotov-Luchanskiy,Altynbek Nukhuly,Larissa Muravlyova et al.
Vilen Molotov-Luchanskiy et al.
Materials and methods: 51 patients with CAP were divided into 2 groups depending on the severity of the pathological process. The first group (I) consisted of 32 patients with moderate severity of pneumonia. The second gr...
The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis [0.03%]
吸烟对COVID-19症状严重程度的影响：系统评价和荟萃分析
Askin Gülsen,Burcu Arpinar Yigitbas,Berat Uslu et al.
Askin Gülsen et al.
Background: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SAR2-COV-2) and was first identified in Wuhan, China, in December of 2019, but quickly spread to the rest of th...
Meta-Analysis
Pulmonary medicine. 2020 Sep 8:2020:7590207. DOI:10.1155/2020/7590207 2020
Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies [0.03%]
COVID-19生还者的肺纤维化：预测因素和风险降低策略
Ademola S Ojo,Simon A Balogun,Oyeronke T Williams et al.
Ademola S Ojo et al.
Although pulmonary fibrosis can occur in the absence of a clear-cut inciting agent, and without a clinically clear initial acute inflammatory phase, it is more commonly associated with severe lung injury. This may be due to respiratory infe...